[HTML][HTML] Genetics and genomics of SARS-CoV-2: A review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection
The outbreak of 2019-novel coronavirus disease (COVID-19), caused by SARS-CoV-2,
started in late 2019; in a short time, it has spread rapidly all over the world. Although some …
started in late 2019; in a short time, it has spread rapidly all over the world. Although some …
Emerging influenza D virus threat: what we know so far!
Influenza viruses, since time immemorial, have been the major respiratory pathogen known
to infect a wide variety of animals, birds and reptiles with established lineages. They belong …
to infect a wide variety of animals, birds and reptiles with established lineages. They belong …
Inhaled RNA therapy: from promise to reality
RNA-based medicine is receiving growing attention for its diverse roles and potential
therapeutic capacity. The largest obstacle in its clinical translation remains identifying a safe …
therapeutic capacity. The largest obstacle in its clinical translation remains identifying a safe …
Nucleic acids biosensors based on metal-organic framework (MOF): Paving the way to clinical laboratory diagnosis
Abstract Development of ultra-sensitive, high specific and cost-effective nucleic acids (NAs)
biosensors is critical for early diagnosis of cancer, genetic diseases and follows up response …
biosensors is critical for early diagnosis of cancer, genetic diseases and follows up response …
Potential therapeutic targets and promising drugs for combating SARS‐CoV‐2
H Zhou, Y Fang, T Xu, WJ Ni, AZ Shen… - British Journal of …, 2020 - Wiley Online Library
As of April 9, 2020, a novel coronavirus (SARS‐CoV‐2) had caused 89,931 deaths and
1,503,900 confirmed cases worldwide, which indicates an increasingly severe and …
1,503,900 confirmed cases worldwide, which indicates an increasingly severe and …
Aptamers—diagnostic and therapeutic solution in SARS-CoV-2
T Wandtke, E Wędrowska, M Szczur… - International journal of …, 2022 - mdpi.com
The SARS-CoV-2 virus is currently the most serious challenge to global public health. Its
emergence has severely disrupted the functioning of health services and the economic and …
emergence has severely disrupted the functioning of health services and the economic and …
Nucleic acid-based technologies targeting coronaviruses
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) is currently creating a global health emergency. This …
syndrome coronavirus 2 (SARS-CoV-2) is currently creating a global health emergency. This …
Nucleic acid-based therapy for coronavirus disease 2019
Abstract The coronavirus disease 2019 (COVID-19), the pandemic that originated in China
has already spread into more than 190 countries, resulting in huge loss of human life and …
has already spread into more than 190 countries, resulting in huge loss of human life and …
From bench side to clinic: Potential and challenges of RNA vaccines and therapeutics in infectious diseases
M Pandey, D Ojha, S Bansal, AB Rode… - Molecular Aspects of …, 2021 - Elsevier
The functional and structural versatility of Ribonucleic acids (RNAs) makes them ideal
candidates for overcoming the limitations imposed by small molecule-based drugs. Hence …
candidates for overcoming the limitations imposed by small molecule-based drugs. Hence …
Lipid-based colloidal nanoparticles for applications in targeted vaccine delivery
Bioactive molecules and their effects have been influenced by their solubility and
administration route. In many therapeutic reagents, the performance of therapeutics is …
administration route. In many therapeutic reagents, the performance of therapeutics is …